Back D - Search Results

1

Mulcahy F, Barry M, Merry C, Back D. Mulcahy F, et al. Among authors: back d. AIDS. 1998 Dec 3;12(17):2361. AIDS. 1998. PMID: 9863887 No abstract available.

2

Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

Merry C, Mulcahy F, Barry M, Gibbons S, Back D. Merry C, et al. Among authors: back d. AIDS. 1997 Feb;11(2):268-9. AIDS. 1997. PMID: 9030388 No abstract available.

3

Hydroxyurea-induced neurotoxicity in HIV disease.

Barry M, Clarke S, Mulcahy F, Back D. Barry M, et al. Among authors: back d. AIDS. 1999 Aug 20;13(12):1592-4. doi: 10.1097/00002030-199908200-00028. AIDS. 1999. PMID: 10465092 No abstract available.

4

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

Moore KH, Barrett JE, Shaw S, Pakes GE, Churchus R, Kapoor A, Lloyd J, Barry MG, Back D. Moore KH, et al. Among authors: back d. AIDS. 1999 Nov 12;13(16):2239-50. doi: 10.1097/00002030-199911120-00006. AIDS. 1999. PMID: 10563709 Clinical Trial.

5

Therapeutic drug monitoring in HIV infection: current status and future directions.

Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, Kurowski M, Luber A, Merry C, Perno CF. Back D, et al. AIDS. 2002 Mar;16 Suppl 1:S5-37. doi: 10.1097/00002030-200203001-00002. AIDS. 2002. PMID: 12035820 Review.

6

Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients.

Hennessy M, Clarke S, Spiers JP, Kelleher D, Mulcahy F, Hoggard P, Back D, Barry M. Hennessy M, et al. Among authors: back d. Antivir Ther. 2004 Feb;9(1):115-22. Antivir Ther. 2004. PMID: 15040543

7

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Barry M, Mulcahy F, Merry C, Gibbons S, Back D. Barry M, et al. Among authors: back d. Clin Pharmacokinet. 1999 Apr;36(4):289-304. doi: 10.2165/00003088-199936040-00004. Clin Pharmacokinet. 1999. PMID: 10320951 Review.

8

Improved tolerability of ritonavir derived from pharmacokinetic principles.

Merry C, Barry M, Gibbons S, Mulcahy F, Back D. Merry C, et al. Among authors: back d. Br J Clin Pharmacol. 1996 Dec;42(6):787. doi: 10.1046/j.1365-2125.1996.d01-3339.x. Br J Clin Pharmacol. 1996. PMID: 8971438 Free PMC article. Clinical Trial. No abstract available.

9

Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases.

Seden K, Khoo S, Back D, Prevatt N, Lamorde M, Byakika-Kibwika P, Mayito J, Ryan M, Merry C. Seden K, et al. Among authors: back d. AIDS. 2013 Mar 13;27(5):675-86. doi: 10.1097/QAD.0b013e32835ca9b4. AIDS. 2013. PMID: 23719345

10

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.

Barry M, Gibbons S, Back D, Mulcahy F. Barry M, et al. Among authors: back d. Clin Pharmacokinet. 1997 Mar;32(3):194-209. doi: 10.2165/00003088-199732030-00003. Clin Pharmacokinet. 1997. PMID: 9084959 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

815 results

Search Page

Filters